120. American College of Obstetricians and Gynecologists’ Committee on Practice–Obstetrics. ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy // Obstet. Gynecol. 2018. Vol. 132, N 1. P. e1–e17. DOI: 10.1097/AOG.0000000000002706. Erratum in: Obstet. Gynecol. 2018. Vol. 132, N 4. P. 1068.
121. Marik P.E., Plante L.A. Venous thromboembolic disease and pregnancy // N. Engl. J. Med. 2008. Vol. 359, N 19. P. 2025–2033. DOI: 10.1056/NEJMra0707993.
122. Kevane B., Donnelly J., D’Alton M., Cooley S., Preston R.J., Ní Ainle F. Risk factors for pregnancy-associated venous thromboembolism: a review // J. Perinat. Med. 2014. Vol. 42, N 4. P. 417–425. DOI: 10.1515/jpm-2013-0207.
123. Nowotny K., Jung T., Höhn A., Weber D., Grune T. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus // Biomolecules. 2015. Vol. 5, N 1. P. 194–222. DOI: 10.3390/biom5010194.
124. Díaz-Pérez F.I., Hiden U., Gauster M., Lang I., Konya V., Heinemann A. et al. Post-transcriptional down regulation of ICAM-1 in feto-placental endothelium in GDM // Cell Adh. Migr. 2016. Vol. 10, N 1–2. P. 18–27. DOI: 10.1080/19336918.2015.1127467.
125. Lemkes B.A., Hermanides J., Devries J.H., Holleman F., Meijers J.C., Hoekstra J.B. Hyperglycemia: a prothrombotic factor? // J. Thromb. Haemost. 2010. Vol. 8, N 8. P. 1663–1169. DOI: 10.1111/j.1538-7836.2010.03910.x.
126. Rydén L., J. Grant P., D. Anker S., Berne C., Cosentino F., Danchin N. еt al. Рекомендации по диабету, предиабету и сердечно-сосудистым заболеваниям. EASD/ESC // Российский кардиологический журнал. 2014. Т. 3. С. 7–61. DOI: 10.15829/1560-4071-2014-3-7-61.
127. Bai J., Ding X., Du X., Zhao X., Wang Z., Ma Z. Diabetes is associated with increased risk of venous thromboembolism: a systematic review and meta-analysis // Thromb. Res. 2015. Vol. 135, N 1. P. 90–95. DOI: 10.1016/j.thromres.2014.11.003.
128. Bleau N., Patenaude V., Abenhaim H.A. Risk of venous thromboembolic events in pregnant patients with autoimmune diseases: a population-based study // Clin. Appl. Thromb. Hemost. 2016. Vol. 22, N 3. P. 285–291. DOI: 10.1177/1076029614553023.
129. Son K.H., Lim N.K., Lee J.W., Cho M.C., Park H.Y. Comparison of maternal morbidity and medical costs during pregnancy and delivery between patients with gestational diabetes and patients with pre-existing diabetes // Diabet Med. 2015. Vol. 32, N 4. P. 477–486. DOI: 10.1111/dme.12656.
130. Sultan A.A., Tata L.J., West J., Fiaschi L., Fleming K.M., Nelson-Piercy C., Grainge M.J. Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom // Blood. 2013. Vol. 121, N 19. P. 3953–3961. DOI: 10.1182/blood-2012-11-469551.
131. Won H.S., Kim D.Y., Yang M.S., Lee S.J., Shin H.H., Park J.B. Pregnancy-induced hypertension, but not gestational diabetes mellitus, is a risk factor for venous thromboembolism in pregnancy // Korean Circ. J. 2011. Vol. 41, N 1. P. 23–27. DOI: 10.4070/kcj.2011.41.1.23.
132. Heit J.A., Leibson C.L., Ashrani A.A., Petterson T.M., Bailey K.R., Melton L.J. 3rd. Is diabetes mellitus an independent risk factor for venous thromboembolism? A population-based case-control study // Arterioscler. Thromb. Vasc. Biol. 2009. Vol. 29, N 9. P. 1399–1405. DOI: 10.1161/ATVBAHA.109.189290.
133. Венозные осложнения во время беременности и послеродовом периоде. Акушерская тромбоэмболия: клинические рекомендации. Москва, 2022.
134. Piazza G., Goldhaber S.Z., Kroll A., Goldberg R.J., Emery C., Spencer F.A. Venous thromboembolism in patients with diabetes mellitus // Am. J. Med. 2012. Vol. 125, N 7. P. 709–716. DOI: 10.1016/j.amjmed.2011.12.004.
135. Blondon M., Casini A., Hoppe K.K., Boehlen F., Righini M., Smith N.L. Risks of venous thromboembolism after cesarean sections: a meta-analysis // Chest. 2016. Vol. 150, N 3. P. 572–596. DOI: 10.1016/j.chest.2016.05.021.
136. Bell E.J., Folsom A.R., Lutsey P.L., Selvin E., Zakai N.A., Cushman M., Alonso A. Diabetes mellitus and venous thromboembolism: a systematic review and meta-analysis // Diabetes Res. Clin. Pract. 2016. Vol. 111. P. 10–18. DOI: 10.1016/j.diabres.2015.10.019.
137. Анестезия и интенсивная терапия у пациенток, получающих антикоагулянты для профилактики и лечения венозных тромбоэмболических осложнений в акушерстве: клинические рекомендации (протокол лечения). Москва, 2018. 48 с.
138. Shen L., Tabaie S., Ivascu N. Viscoelastic testing inside and beyond the operating room // J. Thorac. Dis. 2017. Vol. 9. Suppl. 4. P. S299–S308. DOI: 10.21037/jtd.2017.03.85.
139. Williams B., McNeil J., Crabbe A., Tanaka K.A. Practical use of thromboelastometry in the management of perioperative coagulopathy and bleeding // Transfus. Med. Rev. 2017. Vol. 31, N 1. P. 11–25. DOI: 10.1016/j.tmrv.2016.08.005.
140. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений // Флебология. 2015. Т. 4. Вып. 2. С. 1–52.
141. Areeruk W., Phupong V. A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor // Sci Rep. 2016. Vol. 6. P. 20638. https://doi.org/10.1038/ srep20638.
142. Pustotina O. Efectiveness of dydrogesterone, 17-OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix // J. Matern. Fetal. Neonatal. Med. 2018. Vol. 31, N 14. P. 1830–1838. https://doi.org/10.1080/14767058.2017.1330406.
143. Зайцева М.А. Роль прогестагенов в лечении невынашивания беременности I триместра: автореф. дис. … канд. мед. наук. СПб., 2018. 24 с.
144. Schindler A.E. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium // Maturitas. 2009. Vol. 65. Suppl1. P. 3–11. Epub 2009 Dec 6. https://doi.org/10.1016/j.maturitas.2009.10.011.